Health Condition 1: null- Metabolic syndrome patients
Conditions
Interventions
Intervention1: Chrominex: 400 mcg capsule orally once daily for 12 weeks
Intervention2: Chromium chloride: capsules
Intervention3: p.emblica plus shilajit: 6 mg + 6 mg one capsule orally once daily fo
Sponsors
DrCGayatri Devi
Dr P Usha Rani
Eligibility
Inclusion criteria
Inclusion criteria: 1.endothelial dysfunction defined as <= 6% change in reflection index (RI) on post salbutamol challenge test and according to â??The International Diabetes Federationâ?? guidelines
Exclusion criteria
Exclusion criteria: Patients with severe uncontrolled hyperglyceamia, uncontrolled hypertension, cardiac arrhythmia, impaired hepatic or renal function, history of malignancy or stroke, smoking, chronic alcoholism, any other serious disease requiring active treatment and treatment with any other herbal supplements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary efficacy measure was a change in endothelial dysfunction as assessed by more than 6% change in reflection index at 12 weeks in all the treatment groups.Timepoint: At baseline and at end of 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| change in oxidative stress markers, serum levels of nitric oxide at 12 weeks in all the treatment groupsTimepoint: 4,8,12weeks | — |
Countries
India
Contacts
Public ContactDr C Gayatri Devi
Nizams Institute of Medical Sciences
Outcome results
None listed